Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Mycosis Fungoides 2Lymphoma, T-Cell, Cutaneous 2Keratosis, Actinic 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Warts 1Squamous Intraepithelial Lesions 1Skin Neoplasms 1Radiodermatitis 1Parapsoriasis 1Non-Melanoma Skin Cancer (NMSC) 1Neoplasms 1Hypogonadism 1Hemangioma, Cavernous 1Hemangioma 1Head and Neck Cancer Patients Treated With Radiotherapy 1Fatigue 1Exanthema 1Eunuchism 1Dermatitis, Contact 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1Carcinoma 1Breast Neoplasms 1Breast Carcinoma In Situ 1

Interventions

Watchful Waiting 1Timolol 1Gels 1Doxycycline 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hemangioma, Cavernous × Gels × Clear all
NCT02145884 2017-02-13

Topical Timolol Gel for the Treatment of Infantile Hemangiomas

Rady Children's Hospital, San Diego

Phase 2 Completed
26 enrolled

Hemangioma, Hemangioma, Cavernous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡